Autolus Therapeutics plc American Depositary Share (AUTL) is a publicly traded Healthcare sector company. As of September 7, 2026, AUTL trades at $2.24 with a market cap of $596.20M and a P/E ratio of -2.11. AUTL moved -2.84% today. Year to date, AUTL is +12.56%; over the trailing twelve months it is +53.42%. Its 52-week range spans $1.11 to $2.70. Analyst consensus is strong buy with an average price target of $8.16. Rallies surfaces AUTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AUTL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.24 |
| Market Cap | $596.20M |
| P/E Ratio | -2.11 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.70 |
| 52-Week Low | $1.11 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $117.39M |
| Net Income | $-280.16M |
| Gross Margin | 15.66% |
6 analysts cover AUTL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.16.